Ep. 388 - Biotech IPOs, CAR T safety & pharma tariffs
Summary Coming Soon
Our AI is still processing this episode. Summaries typically appear within 24-48 hours of episode release.
Want to be notified when this summary is ready? Subscribe to get weekly digests with AI summaries of all new episodes.
You just read a 3-minute summary of a 29-minute episode.
Get BioCentury This Week summarized like this every Monday — plus up to 2 more podcasts, free.
Pick Your Podcasts — FreeKeep Reading
More from BioCentury This Week
Ep. 387 - Psychedelics at FDA, Mike Davis’ CDER & tRNAs
Sep 15 · 35 min
Marketing School
$100M in Email With No Employees? Neil Isn't Buying It
Sep 23
More from BioCentury This Week
Ep. 386 - Novartis misses, pharma deals analysis, MFN carve-outs
Sep 9 · 35 min
Syntax
1041: What are normies using AI for?
Sep 23
More from BioCentury This Week
We summarize every new episode. Want them in your inbox?
Ep. 387 - Psychedelics at FDA, Mike Davis’ CDER & tRNAs
Ep. 386 - Novartis misses, pharma deals analysis, MFN carve-outs
Ep. 385 - MFN deals, Lilly takeout, FDA pick Overton
Ep. 384 - Back to School Special: The global FIH trials race
Ep. 383 - Moderna, Genentech obesity deal, Trump's FDA pick
Similar Episodes
Related episodes from other podcasts
Marketing School
Sep 23
$100M in Email With No Employees? Neil Isn't Buying It
Syntax
Sep 23
1041: What are normies using AI for?
Bankless
Sep 23
FOMO, Meme Stocks and Robinhood Chain | Andy8052 & Eric Conner
The Product Experience
Sep 23
How to fix your product roadmap — Matt Feczko (Director of Product Ops, Ocado Technology)
a16z Podcast
Sep 23
Amjad Masad on Rethinking College for the AI Era
This podcast is featured in Best Biotech Podcasts (2026) — ranked and reviewed with AI summaries.
You're clearly into BioCentury This Week.
Every Monday, we deliver AI summaries of the latest episodes from BioCentury This Week and 192+ other podcasts. Free for one show.
Start My Monday DigestNo credit card · Unsubscribe anytime